+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Companion Animal Health Market Size, Share & Trends Analysis Report by Animal Type (Dogs, Cat, Equine), by Product (Pharmaceuticals, Diagnostics), by Distribution Channel, by End Use, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • April 2022
  • Region: United States
  • Grand View Research
  • ID: 5595782

The U.S. companion animal health market size is expected to reach USD 11.39 billion by 2030. It is expected to expand at a CAGR of 10.2% from 2022 to 2030. The rising number of pet owners seeking better healthcare services, healthier quality foods, and high-end grooming and training services for their companion animals is a major driver for this market. According to the American Pet Products Association (National Pet Owners Survey), 85 million households in the U.S. own a pet, especially dogs, out of which 60.2 million own multiple pets. Moreover, high-income families amounted to approximately 60% of the total spending. In recent years, pet adoption has shown immense growth. This is primarily attributed to the fact that people are healthier and happier in the presence of pets, as found by the Human-Animal Bond Research Initiative Foundation (HABRI).

With the rising adoption of companion animals and growing concerns over their health, there comes a direct association with pet insurance. Presently, pet insurance accounts for a small segment of the insurance industry. The Covid-19 pandemic positively impacted the market growth in the U.S. Key players such as Boehringer Ingelheim Animal Health, Chewy, Elanco, MWI Animal Health, Covetrus, and PetIQ focused on expanding their telemedicine solutions into the market as governments relaxed governance to enable more flexible veterinary examinations during the coronavirus pandemic.

Approval of novel therapeutics and companion animal vaccines continues to present this market with lucrative growth opportunities. Ongoing trends for the adoption of e-commerce, pet insurance, veterinary telemedicine, point of care diagnostic testing, and digitalization of veterinary practices are further accelerated by the crisis of COVID-19.

Groundbreaking technological advances are rapidly transforming the pet health industry. These expansions are maximizing the potential for growth. Companies are taking strategic initiatives in pet health, such as the adoption of big data, wearable technologies to monitor pet health, and the inclusion of stem cell therapy. Moreover, established players are focusing on expanding their portfolios. For instance, Elanco acquired Bayer AG’s animal health business unit in August 2019.

The U.S. captured a substantial share of the market. The share attained by this country is primarily a consequence of the presence of prominent market players undertaking extensive expansion strategies. Moreover, the increasing number of R&D investments initiated by the companies is one of the key potential growth factors presumed to be responsible for the sizeable share garnered by the U.S.

U.S. Companion Animal Health Market Report Highlights

  • Based on animal type, the dog segment held the dominant share in 2021 due to the increasing spending on pet care, specifically in developed regions
  • By product, the pharmaceuticals segment is expected to gain popularity in the coming years owing to the growing demand to increase pet longevity and rising R&D activities
  • On the basis of distribution channel, the e-commerce segment is anticipated to witness rapid growth over the forecast period due to the increased convenience offered to pet owners
  • The veterinary hospitals and clinics end-use segment held the largest revenue share of over 80.0% in 2021 due to the growing demand for services such as clinical pathology, toxicology tests, and therapy
  • Vetiquinol S.A., Zoetis, Merck, Ceva Santé Animale, Boehringer Ingelheim GmbH, and Elanco are some of the major market participants due to their product offerings and strong regional presence
  • Companies are adopting various strategies to gain competitive advantages, such as new product development, partnerships, mergers and acquisitions, collaborations, and regional expansion


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the U.S. Companion Animal Health Market

What is the estimated value of the U.S. Companion Animal Health Market?

The U.S. Companion Animal Health Market was estimated to be valued at $5.26 Billion in 2022.

What is the growth rate of the U.S. Companion Animal Health Market?

The growth rate of the U.S. Companion Animal Health Market is 10.2%, with an estimated value of $11.39 Billion by 2030.

What is the forecasted size of the U.S. Companion Animal Health Market?

The U.S. Companion Animal Health Market is estimated to be worth $11.39 Billion by 2030.

Who are the key companies in the U.S. Companion Animal Health Market?

Key companies in the U.S. Companion Animal Health Market include Merck Animal Health, Ceva Santé Animale, Vetiquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Bayer AG, Elanco, Virbac, Inc. and Dechra Pharmaceuticals.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Animal Type
1.1.2 Product
1.1.3 Distribution Channel
1.1.4 End Use
1.1.5 Etimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Companion Animal Health Market Outlook, 2017-2030 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3 U.S. Companion Animal Health Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.1.1 Global Companion Animal Health Market Outlook, 2017-2030 (USD Million)
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.1.1 Investments in the U.S. Companion Animal Health
3.4.2 Distribution channel analysis
3.4.3 User perspective analysis
3.4.3.1 Consumer Behavior Analysis
3.4.3.2 Pet Animal Owner Profiles
3.4.3.3 Market Influencer Analysis
3.5 Technology Overview
3.5.1 Technology Timeline Veterinary orthopedics changing technology & adoption
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & Compliances in the U.S.
3.7 U.S. Companion Animal Health Market dynamics
3.7.1 Market driver analysis
3.7.1.1 Rising number of companion ownership
3.7.1.2 Increase in number of government initiatives
3.7.1.3 Increasing prevalence of zoonotic diseases
3.7.2 Market restraint analysis
3.7.2.1 Increase in advent of counterfit Drugs
3.7.3 Industry Challenges
3.7.3.1 Short product exclusivity
3.8 U.S. Companion Animal Health Market Analysis Tools
3.8.1 Industry Analysis: Poter’s
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Threat Of Substitutes
3.8.1.4 Threat Of New Entrants
3.8.1.5 Competitive Rivalry
3.8.2 SWOT analysis, by factor (political & legal, economic and technological)
3.8.2.1 Political Landscape
3.8.2.2 Economic Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1 Joint Ventures
3.8.3.2 Mergers & Acquisitions
3.8.3.3 Licensing & Partnership
3.8.3.4 Technology Collaborations
3.8.4 Market Entry Strategies
3.9 U.S. Companion Animal Health Market: Covid-19 Impact Analysis
Chapter 4 U.S. Companion Animal Health Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Market Participation Categorization
4.1.1.1 Market Leader
4.1.1.2 Innovators
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key Customers
4.3 Opportunity Analysis
4.3.1 U.S. Companion Animal Health: Company Market Share Analysis
4.3.2 Public Companies
4.3.2.1 Competitive dashboard analysis
4.3.2.2 Company market position analysis
4.3.3 Private Companies
4.3.3.1 List of key emerging companies
Chapter 5 U.S. Companion Animal Health Market: Animal Type Estimates & Trend Analysis
5.1 Animal Type Market Share Analysis, 2021 & 2030
5.2 Animal Type Dashboard
5.3 U.S. Companion Animal Health Market, by Animal Type, 2017 to 2030
5.4 Dogs
5.4.1 Dogs market estimates and forecasts, 2017-2030 (USD Million)
5.5 Equine
5.5.1 Equine market estimates and forecasts, 2017-2030 (USD Million)
5.6 Cats
5.6.1 cats market estimates and forecasts, 2017-2030 (USD Million)
5.7 Sheep & Goats
5.7.1 Sheep & Goats market estimates and forecasts, 2017-2030 (USD Million)
5.8 Companion Poultry
5.8.1 Companion Poultry market estimates and forecasts, 2017-2030 (USD Million)
Chapter 6 U.S. Companion Animal Health Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Product Dashboard
6.3 U.S. Companion Animal Health Market, by Product, 2017 to 2030
6.4 Vaccines
6.4.1 Vaccines market estimates and forecasts, 2017-2030 (USD Million)
6.5 Pharmaceuticals
6.5.1 Pharmaceuticals market estimates and forecasts, 2017-2030 (USD Million)
6.5.2 OTC
6.5.2.1 OTC drugs market estimates and forecasts, 2017-2030 (USD Million)
6.5.3 prescription
6.5.3.1 prescription drugs market estimates and forecasts, 2017-2030 (USD Million)
6.6 Feed Additives
6.6.1 Feed additives market estimates and forecasts, 2017-2030 (USD Million)
6.7 Diagnostics
6.7.1 Diagnostics market estimates and forecasts, 2017-2030 (USD Million)
6.8 Others
6.8.1 Other U.S. Companion Animal Health Products market estimates and forecasts, 2017-2030 (USD Million)
Chapter 7 U.S. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
7.1 Distribution Channel Market Share Analysis, 2021 & 2030
7.2 Distribution Channel Dashboard
7.3 U.S. Companion Animal Health Market by Distribution Channel 2017 to 2030
7.3.1 Retail
7.3.2 retail market estimates and forecasts, 2017-2030 (USD Million)
7.4 E-commerce
7.4.1 e-commerce market estimates and forecasts, 2017-2030 (USD Million)
7.5 Hospital Pharmacy
7.5.1 Hospital pharmacy market estimates and forecasts, 2017-2030 (USD Million)
Chapter 8 U.S. Companion Animal Health Market: End-use Estimates & Trend Analysis
8.1 End-use Market Share Analysis, 2021 & 2030
8.2 End-use Dashboard
8.3 U.S. Companion Animal Health Market by End-use, 2017 to 2030
8.4 Point-of-care/In-house Testing
8.4.1 Point-of-care/In-house Testing market estimates and forecasts, 2017-2030 (USD Million)
8.5 Veterinary Hospitals & Clinics
8.5.1 Veterinary hospitals & clinics market estimates and forecasts, 2017-2030 (USD Million)
8.6 Others
8.6.1 Others market estimates and forecasts, 2017-2030 (USD Million)
Chapter 9 Company Profiles
9.1 Merck Animal Health
9.1.1 Company overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Ceva Santé Animale
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Vetiquinol S.A.
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Zoetis
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Boehringer Ingelheim GmbH
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Bayer AG
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Elanco
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Virbac, Inc.
9.8.1 Company overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Norbrook Inc.
9.9.1 Company overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Dechra Pharmaceuticals
9.10.1 Company overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Patterson Companies, Inc.
9.11.1 Company overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Vedco Inc.
9.12.1 Company overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 MWI Animal Health
9.13.1 Company overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Covetrus
9.14.1 Company overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Ellevet Sciences
9.15.1 Company overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.15.4 Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Products in the pipeline
Table 4 Deals & strategic alliances in U.S. Companion Animal Health
Table 5 List of Distributors
Table 6 List of key emerging companies

List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 U.S. companion animal health market revenue, 2017 - 2030 (USD Million)
Fig. 11 U.S. Companion animal health market snapshot
Fig. 12 Companion animal health market revenue, 2017 - 2030 (USD Million)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Drug development process for companion animal segment
Fig. 15 Companion animal health: Market influencing factors
Fig. 16 Companion animal health: Market dynamics
Fig. 17 U.S. companion animal health market dynamics
Fig. 18 U.S. Companion Animal Health market driver impact
Fig. 19 U.S. Pet ownership statistics by animal type
Fig. 20 U.S. Pet ownership statistics till 2021
Fig. 21 U.S. Companion Animal Health market restraint impact
Fig. 22 U.S. Companion Animal Health market: Porter’s five forces analysis
Fig. 23 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 24 Market entry strategies
Fig. 25 Market participant categorization
Fig. 26 Company Market Share Analysis, 2021 (%)
Fig. 27 Competitive dashboard analysis
Fig. 28 Company market position analysis
Fig. 29 U.S. companion animal health market: Animal type movement analysis
Fig. 30 U.S. companion animal health market animal type dashboard
Fig. 31 U.S. companion animal health market by animal type
Fig. 32 U.S. dogs market, 2017 - 2030 (USD Million)
Fig. 33 U.S. Equine market, 2017 - 2030 (USD Million)
Fig. 34 U.S. cats market, 2017 - 2030 (USD Million)
Fig. 35 U.S. sheep & goats market, 2017 - 2030 (USD Million)
Fig. 36 U.S. companion poultry market, 2017 - 2030 (USD Million)
Fig. 37 U.S. companion animal health market: Product movement analysis
Fig. 38 U.S. companion animal health product dashboard
Fig. 39 U.S. companion animal health Market, by Product, 2017 to 2030
Fig. 40 U.S. vaccines market, 2017 - 2030 (USD Million)
Fig. 41 U.S. pharmaceuticals market, 2017 - 2030 (USD Million)
Fig. 42 U.S. OTC drugs market, 2017 - 2030 (USD Million)
Fig. 43 U.S. prescription drugs market, 2017 - 2030 (USD Million)
Fig. 44 U.S. feed additives market, 2017 - 2030 (USD Million)
Fig. 45 U.S. diagnostics market, 2017 - 2030 (USD Million)
Fig. 46 U.S. others market, 2017 - 2030 (USD Million)
Fig. 47 U.S. companion animal health market: Distribution channel movement analysis
Fig. 48 U.S. companion animal health market distribution channel dashboard
Fig. 49 U.S. Companion Animal Health Market by Distribution Channel 2017 to 2030
Fig. 50 U.S. retail market, 2017 - 2030 (USD Million
Fig. 51 U.S. e-commerce market, 2017 - 2030 (USD Million
Fig. 52 U.S. hospital pharmacy market, 2017 - 2030 (USD Million)
Fig. 53 U.S. companion animal health market: End-use movement analysis
Fig. 54 U.S. companion animal health market End-use dashboard
Fig. 55 U.S. companion animal health Market by End-use, 2017 to 2030
Fig. 56 U.S. point-of-care/in-house testing market, 2017 - 2030 (USD Million)
Fig. 57 U.S. veterinary hospitals & clinics market, 2017 - 2030 (USD Million)
Fig. 58 U.S. others market, 2017 - 2030 (USD Million)

Companies Mentioned

  • Merck Animal Health
  • Ceva Santé Animale
  • Vetiquinol S.A.
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Elanco
  • Virbac, Inc.
  • Norbrook Inc.
  • Dechra Pharmaceuticals
  • Patterson Companies, Inc.
  • Vedco Inc.
  • Mwi Animal Health
  • Covetrus
  • Ellevet Sciences

Methodology

Loading
LOADING...